Topic List : Chronic Disease
Peering into kids’ bones
Mary Leonard, chair of the Department of Pediatrics at Stanford, works to understand exactly how chronic diseases hurt children’s bone health.
Diabetes center gets $7.7 million
With the grant, Stanford joins 16 other federal research centers across the country dedicated to the prevention and treatment of diabetes.
Psoriatic arthritis drug shows promise
In a randomized clinical trial conducted by researchers at Stanford and more than 100 other medical centers, psoriatic arthritis patients given an injectable biologic drug for 24 weeks showed substantial improvement compared with patients who received placebo injections.
First possible drug treatment for lymphedema
Collaboration between two Stanford labs has resulted in the discovery of a molecular cause for lymphedema and the first possible drug treatment for it.
Testing new insulin delivery systems for kids
Researchers at the School of Medicine and Lucile Packard Children’s Hospital are testing easier ways for younger children with Type 1 diabetes to get the doses of insulin they need.
Insulin resistance, tired mice
Shutting off a gene implicated in insulin resistance leads to damaged mitochondria and decreased exercise capacity in mice.
Podcast: A conversation with Laura Hillenbrand
Author Laura Hillenbrand discusses her illness, her newfound strengths and how she is leaving frailty behind.
Tackling China’s rising chronic disease burden
A graduate seminar in Beijing brought together students from Stanford and China to consider solutions to China’s growing problems of cancer, stroke and heart disease.
How age affects pancreatic function
A Stanford-led national collaboration to procure and analyze human pancreatic tissue from deceased donors illustrates how the organ’s function changes as we age, and could point the way toward new diabetes treatments.
Hamad on neighborhoods and health
The Stanford researcher co-authored a new study showing that refugees assigned to the most deprived Swedish neighborhoods were 15 to 30 percent more likely to develop Type 2 diabetes.